BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kartamihardja AA, Nakajima T, Kameo S, Koyama H, Tsushima Y. Distribution and clearance of retained gadolinium in the brain: differences between linear and macrocyclic gadolinium based contrast agents in a mouse model. Br J Radiol 2016;89:20160509. [PMID: 27459250 DOI: 10.1259/bjr.20160509] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 5.6] [Reference Citation Analysis]
Number Citing Articles
1 Davies J, Marino M, Smith APL, Crowder JM, Larsen M, Lowery L, Castle J, Hibberd MG, Evans PM. Repeat and single dose administration of gadodiamide to rats to investigate concentration and location of gadolinium and the cell ultrastructure. Sci Rep 2021;11:13950. [PMID: 34230532 DOI: 10.1038/s41598-021-93147-2] [Reference Citation Analysis]
2 Rasschaert M, Emerit A, Fretellier N, Factor C, Robert P, Idée JM, Corot C. Gadolinium Retention, Brain T1 Hyperintensity, and Endogenous Metals: A Comparative Study of Macrocyclic Versus Linear Gadolinium Chelates in Renally Sensitized Rats. Invest Radiol 2018;53:328-37. [PMID: 29329151 DOI: 10.1097/RLI.0000000000000447] [Cited by in Crossref: 30] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
3 Richter H, Bücker P, Dunker C, Karst U, Kircher PR. Gadolinium deposition in the brain of dogs after multiple intravenous administrations of linear gadolinium based contrast agents. PLoS One 2020;15:e0227649. [PMID: 32012163 DOI: 10.1371/journal.pone.0227649] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
4 Jost G, Frenzel T, Boyken J, Lohrke J, Nischwitz V, Pietsch H. Long-term Excretion of Gadolinium-based Contrast Agents: Linear versus Macrocyclic Agents in an Experimental Rat Model. Radiology 2019;290:340-8. [DOI: 10.1148/radiol.2018180135] [Cited by in Crossref: 50] [Cited by in F6Publishing: 36] [Article Influence: 25.0] [Reference Citation Analysis]
5 Thomas AM, Xu J, Calabresi PA, van Zijl PCM, Bulte JWM. Monitoring diffuse injury during disease progression in experimental autoimmune encephalomyelitis with on resonance variable delay multiple pulse (onVDMP) CEST MRI. Neuroimage 2020;204:116245. [PMID: 31605825 DOI: 10.1016/j.neuroimage.2019.116245] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Rasschaert M, Weller RO, Schroeder JA, Brochhausen C, Idée JM. Retention of Gadolinium in Brain Parenchyma: Pathways for Speciation, Access, and Distribution. A Critical Review. J Magn Reson Imaging 2020;52:1293-305. [PMID: 32246802 DOI: 10.1002/jmri.27124] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
7 Blumfield E, Swenson DW, Iyer RS, Stanescu AL. Gadolinium-based contrast agents - review of recent literature on magnetic resonance imaging signal intensity changes and tissue deposits, with emphasis on pediatric patients. Pediatr Radiol 2019;49:448-57. [PMID: 30923876 DOI: 10.1007/s00247-018-4304-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 11.5] [Reference Citation Analysis]
8 Robert P, Frenzel T, Factor C, Jost G, Rasschaert M, Schuetz G, Fretellier N, Boyken J, Idée JM, Pietsch H. Methodological Aspects for Preclinical Evaluation of Gadolinium Presence in Brain Tissue: Critical Appraisal and Suggestions for Harmonization-A Joint Initiative. Invest Radiol 2018;53:499-517. [PMID: 29659381 DOI: 10.1097/RLI.0000000000000467] [Cited by in Crossref: 30] [Cited by in F6Publishing: 10] [Article Influence: 15.0] [Reference Citation Analysis]
9 Wang ST, Hua ZX, Fan DX, Zhang X, Ren K. Gadolinium Retention and Clearance in the Diabetic Brain after Administrations of Gadodiamide, Gadopentetate Dimeglumine, and Gadoterate Meglumine in a Rat Model. Biomed Res Int 2019;2019:3901907. [PMID: 31192255 DOI: 10.1155/2019/3901907] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
10 Gianolio E, Bardini P, Arena F, Stefania R, Di Gregorio E, Iani R, Aime S. Gadolinium Retention in the Rat Brain: Assessment of the Amounts of Insoluble Gadolinium-containing Species and Intact Gadolinium Complexes after Repeated Administration of Gadolinium-based Contrast Agents. Radiology 2017;285:839-49. [PMID: 28873047 DOI: 10.1148/radiol.2017162857] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 16.3] [Reference Citation Analysis]
11 Erdoğan MA, Apaydin M, Armagan G, Taskiran D. Evaluation of toxicity of gadolinium-based contrast agents on neuronal cells. Acta Radiol 2021;62:206-14. [PMID: 32366109 DOI: 10.1177/0284185120920801] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Tedeschi E, Caranci F, Giordano F, Angelini V, Cocozza S, Brunetti A. Gadolinium retention in the body: what we know and what we can do. Radiol med 2017;122:589-600. [DOI: 10.1007/s11547-017-0757-3] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 10.0] [Reference Citation Analysis]
13 Choi JW, Moon WJ. Gadolinium Deposition in the Brain: Current Updates.Korean J Radiol. 2019;20:134-147. [PMID: 30627029 DOI: 10.3348/kjr.2018.0356] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 18.3] [Reference Citation Analysis]
14 Huang XX, Jiang RH, Xu XQ, Zu QQ, Wu FY, Liu S, Shi HB. Ischemic Stroke Increased Gadolinium Deposition in the Brain and Aggravated Astrocyte Injury After Gadolinium-Based Contrast Agent Administration: Linear Versus Macrocyclic Agents. J Magn Reson Imaging 2021;53:1282-92. [PMID: 33555617 DOI: 10.1002/jmri.27407] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Schlemm L, Radbruch H, Brandt AU, Scheel M, Paul F. Histopathologic Assessment of Neurotoxicity after Repeated Administration of Gadodiamide in Healthy Rats. Radiology 2017;282:925-6. [DOI: 10.1148/radiol.2017162394] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
16 Kartamihardja AAP, Hanaoka H, Andriana P, Kameo S, Takahashi A, Koyama H, Tsushima Y. Quantitative analysis of Gd in the protein content of the brain following single injection of gadolinium-based contrast agents (GBCAs) by size exclusion chromatography. Br J Radiol 2019;92:20190062. [PMID: 31045442 DOI: 10.1259/bjr.20190062] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
17 Di Gregorio E, Ferrauto G, Furlan C, Lanzardo S, Nuzzi R, Gianolio E, Aime S. The Issue of Gadolinium Retained in Tissues: Insights on the Role of Metal Complex Stability by Comparing Metal Uptake in Murine Tissues Upon the Concomitant Administration of Lanthanum- and Gadolinium-Diethylentriamminopentaacetate. Invest Radiol 2018;53:167-72. [PMID: 28990973 DOI: 10.1097/RLI.0000000000000423] [Cited by in Crossref: 28] [Cited by in F6Publishing: 5] [Article Influence: 14.0] [Reference Citation Analysis]
18 Frenzel T, Apte C, Jost G, Schöckel L, Lohrke J, Pietsch H. Quantification and Assessment of the Chemical Form of Residual Gadolinium in the Brain After Repeated Administration of Gadolinium-Based Contrast Agents: Comparative Study in Rats. Invest Radiol 2017;52:396-404. [PMID: 28125438 DOI: 10.1097/RLI.0000000000000352] [Cited by in Crossref: 141] [Cited by in F6Publishing: 48] [Article Influence: 47.0] [Reference Citation Analysis]
19 Kanal E, Patton TJ, Krefting I, Wang C. Nephrogenic Systemic Fibrosis Risk Assessment and Skin Biopsy Quantification in Patients with Renal Disease following Gadobenate Contrast Administration. AJNR Am J Neuroradiol 2020;41:393-9. [PMID: 32115422 DOI: 10.3174/ajnr.A6448] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
20 Lohrke J, Frisk AL, Frenzel T, Schöckel L, Rosenbruch M, Jost G, Lenhard DC, Sieber MA, Nischwitz V, Küppers A, Pietsch H. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents. Invest Radiol 2017;52:324-33. [PMID: 28323657 DOI: 10.1097/RLI.0000000000000344] [Cited by in Crossref: 105] [Cited by in F6Publishing: 44] [Article Influence: 35.0] [Reference Citation Analysis]
21 Rasschaert M, Idée JM, Robert P, Fretellier N, Vives V, Violas X, Ballet S, Corot C. Moderate Renal Failure Accentuates T1 Signal Enhancement in the Deep Cerebellar Nuclei of Gadodiamide-Treated Rats. Invest Radiol 2017;52:255-64. [PMID: 28067754 DOI: 10.1097/RLI.0000000000000339] [Cited by in Crossref: 35] [Cited by in F6Publishing: 16] [Article Influence: 8.8] [Reference Citation Analysis]
22 Wiacek A, Oluyemi E, Myers K, Mullen L, Bell MAL. Coherence-Based Beamforming Increases the Diagnostic Certainty of Distinguishing Fluid from Solid Masses in Breast Ultrasound Exams. Ultrasound Med Biol 2020;46:1380-94. [PMID: 32122720 DOI: 10.1016/j.ultrasmedbio.2020.01.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 7.0] [Reference Citation Analysis]
23 Boyken J, Frenzel T, Lohrke J, Jost G, Pietsch H. Gadolinium Accumulation in the Deep Cerebellar Nuclei and Globus Pallidus After Exposure to Linear but Not Macrocyclic Gadolinium-Based Contrast Agents in a Retrospective Pig Study With High Similarity to Clinical Conditions. Invest Radiol 2018;53:278-85. [PMID: 29319556 DOI: 10.1097/RLI.0000000000000440] [Cited by in Crossref: 30] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
24 Robert P, Fingerhut S, Factor C, Vives V, Letien J, Sperling M, Rasschaert M, Santus R, Ballet S, Idée J, Corot C, Karst U. One-year Retention of Gadolinium in the Brain: Comparison of Gadodiamide and Gadoterate Meglumine in a Rodent Model. Radiology 2018;288:424-33. [DOI: 10.1148/radiol.2018172746] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 22.0] [Reference Citation Analysis]